Polymorphisms in the hypoxia inducible factor-1α gene (HIF1A) are associated with the renal cell carcinoma phenotype

Cancer Genetics and Cytogenetics

Volumn 153, Issue 2, 2004, Pages 122-126

  Ollerenshaw, Martin ^a   Page, Toby ^a   Hammonds, John ^b   Demaine, Andrew ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; OXYGENASE; PROLINE; SERINE; THREONINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GENETICS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; HYDROXYLATION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; REGULATORY MECHANISM; STATISTICAL ANALYSIS;

AMINO ACID SUBSTITUTION; CARCINOMA, RENAL CELL; EXONS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; TRANSCRIPTION FACTORS;

EID: 9944252820     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.01.014     Document Type: Article

References (18)

1. S. Storkel, J.N. Eble, K. Adlakha, M. Amin, M.L. Blute, D.G. Bostwick, M. Darson, B. Delahunt, and K. Iczkowski Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 80 1997 987 989
2. C. Herbst, H. Kosmehl, K.J. Stiller, A. Berndt, M. Eiselt, J. Schubert, and D. Katenkamp Evaluation of microvessel density by computerised image analysis in human renal cell carcinoma: correlation to pT category, nuclear grade, proliferative activity and occurrence of metastasis J Cancer Res Clin Oncol 124 1998 141 147
3. W.G. Kaelin Jr., and Maher E.R. The VHL tumour-suppressor gene paradigm Trends Genet 14 1998 423 426
4. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, and P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
5. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J Biol Chem 240 1995 1230 1237
6. 2 tension Proc Natl Acad Sci U S A 92 1995 5510 5514
7. M. Krieg, R. Haas, H. Brauch, T. Acker, I. Flamme, and K.H. Plate Up-regulation of hypoxia-inducible factor HIF-1α and HIF-2α under normoxic condition in renal carcinoma cell by von Hippel-Lindau tumor suppresser gene loss of function Oncogene 19 2000 5435 5443
8. 2 sensing Science 292 2001 464 468
9. 2-regulated prolyl hydroxylation Science 292 2001 468 472
10. A.C. Epstein, J.M. Gleadle, L.A. McNeill, K.S. Hewitson, J. O'Rourke, D.R. Mole, M. Mukherji, E. Metzen, M.I. Wilson, A. Dhanda, Y.M. Tian, N. Masson, D.L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P.H. Maxwell, C.W. Pugh, C.J. Schofield, and P.J. Ratcliffe C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54
11. T. Pereira, X. Zheng, J.L. Ruas, K. Tanimoto, and L. Poellinger Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor gene product J Biol Chem 278 2003 6816 6823
12. K.S. Hewitson, L.A. McNeill, M.V. Riordan, Y.M. Tian, A.N. Bullock, R.W.D. Welford, J.M. Elkins, N.J. Oldham, S. Bhattacharya, J.M. Gleadle, P.J. Ratcliffe, C.W. Pugh, and C.J. Schofield Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family J Biol Chem 277 2002 26351 26355
13. D. Lando, D.J. Peet, J.J. Gorman, D.A. Whelan, M.L. Whitelaw, and R.K. Bruick FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor Genes Dev 16 2002 1466 1471
14. L.A. McNeill, K.S. Hewitson, J.M. Gleadle, L.E. Horsfall, N.J. Oldham, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, and C.J. Schofield The use of dioxygen by HIF prolyl hydroxylase (PHD1) Bioorg Med Chem Lett 12 2002 1547 1550
15. J.M. Elkins, K.S. Hewitson, L.A. McNeill, J.F. Seibel, I. Schlemminger, C.W. Pugh, P.J. Ratcliffe, and C.J. Schofield Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1α J Biol Chem 278 2003 1802 1806
16. S.C. Clifford, D. Astuti, L. Hooper, P.H. Maxwell, P.J. Ratcliffe, and E.R. Maher The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma Oncogene 20 2001 5067 5074
17. K. Tanimoto, K. Yoshiga, H. Eguchi, M. Kaneyasu, K. Ukon, T. Kumazaki, N. Oue, W. Yasui, K. Imai, K. Nakachi, L. Poellinger, and M. Nishiyama Hypoxia-inducible factor-1α polymorphisms associated with enhanced transactivation capacity, implying clinical significance Carcinogenesis 24 2003 1779 1783
18. M.I. Koukourakis, A. Giatromanolaki, J. Skarlatos, L. Corti, S. Blandamura, M. Piazza, K.C. Gatter, and A.L. Harris Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy Cancer Res 61 2001 1830 1832